Summary
Insertion into the mouse genome of the hybrid oncogene made up of bovine vasopressin gene derived 5′ upstream sequences and the coding sequences of SV40 large T-antigen promoted tumours in anterior pituitary and endocrine pancreas of mice bearing this transgene. In order to investigate the morphology of the steps in the neoplastic process, we used light and electron microscopy to study these organs in 42 animals belonging to the 3rd, 4th and 5th generations, subdivided into 4 age groups from 20 days to 100 days of life. Antibodies to large T-antigen were used to identify sites of expression of the hybrid oncogene, thus monitoring the steps in neoplastic transformation. Large T-antigen immunoreactivity was identified in dysplastic lesions of younger animals and in both dysplastic lesions and tumours of older mice. Insulin (100% of cases) and pancreatic polypeptide (25% of cases) immunoreactivities were revealed in pancreatic lesions but no hormonal immunoreactivity was detected in the pituitary lesions. The ultrastructural study confirmed that the majority cell population of the pancreatic neoplasms was B-type and that the anterior pituitary tumours were poorly granulated. The subcellular localization of large T-antigen immunoreactivity was investigated by the immunogold method and was confined to the heterochromatin of tumour cell nuclei. These findings provide evidence for the dysplasia-neoplasia sequence in the genesis of endocrine tumours of pituitary and pancreas of transgenic mice. The vasopressin-SV40 large T-antigen transgenic mice may therefore be an useful model for the study of endocrine cell oncogenesis,
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams TE, Alpert S, Hanahan D (1987) Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells: Nature 324:223–227
Brinster RL, Chen HY, Messing A, Van Dyke T, Levine AJ, Palmiter RD (1984) Transgenic mice harbouring SV40 T-antigen genes develop characteristic brain tumours. Cell 37:367–379
Fiocca R, Rindi G, Capella C, Grimelius L, Polak JM, Schwartz TW, Yanaihara N, Solcia E (1987) Glucagon, glicentin, proglucagon, PYY, PP and pro-PP icosapeptide immunoreactivities of rectal carcinoid tumours and related non-tumour cells. Reg Pep 17:8–29
Hanahan D (1985) Heritable formation of pancreatic B-cell tumours in transgenic mice expressing recombinant insulin simian virus 40 oncogenes. Nature 315:115–122
Heitz PU (1984) Pancreatic endocrine tumours. In: Heitz PU, Klöppel G (eds) Pancreatic Pathology. Churchill Livingstone, Edinburgh London Melbourne New York, pp 206–232
Howell SL, Fink CJ, Lacy PE (1969) Isolation and properties of secretory granules from rat islets of Langerhans. J Cell Biol 41:154–161
Hsu SM, Rainel L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577–580
Karnovsky MJ (1965) A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 27:137A
Klöppel G, Lewson S (1984) Anatomy and physiology of the endocrine pancreas. In: Klöppel G, Heitz PhU (eds) Pancreatic pathology. Churchill Livingstone, Edinburgh London Melbourne New York, pp 133–153
Lacy PE (1961) Electron microscopy of the Beta cell of the pancreas. Am J Med 31:851–859
Lacy PE (1962) Electron microscopy of the islets of Langerhans. Diabetes 11:509–513
Larsson LI, Ljungberg O, Sundler F, Hakanson R, Svenson SO, Rehfeld JF, Stadil F, Holst JJ (1973) Antropyloric gastrinoma associated with nesidioblastosis and proliferation of islets. Virchow Arch A (Pathol Anat) 360:305–314
Murphy D, Bishop AE, Rindi G, Murphy MN, Stamp GWH, Hanson J, Polak JM, Hogan B (1987) Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumours of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type I. Am J Pathol (in press)
Nakane PK (1970) Classification of anterior pituitary cell types with immunoenzyme histochemistry. J Histochem Cytochem 18:9–20
Orci L (1981) Banting lecture 1981 - Macro and micro domains in the endocrine pancreas. Diabetes 31:538–565
Ornitz DM, Palmiter RD, Messing A, Hammer RE, Pinkert CA, Brinster RLT (1985) Elastase I promoter directs expression of human growth hormone and SV40 T-antigen to pancreatic acinar cells in transgenicmice. Cold Spring Harbor Symp Quant Biol 50:399–409
Porte D, Halter JB (1981) The endocrine pancreas and diabetes mellitus. In: Willams RH (ed) Textbook of Endocrinology. WB Saunders, Philadelphia London Toronto, pp 716–843
Power RF, Holm R, Bishop AE, Varndell IM, Alpert S, Hanahan D, Polak JM (1987) Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth. Gut 28:121–129
Rigby PWJ, Lane DE (1983) Structure and function of Simian Virus 40 large T-antigen. In: Klein G (ed) Advance in Virol Oncology, Raven Press, New York, vol 3, pp 31–57
Scopsi L, Wang BL, Larsson LI (1986) Non-specific immunocytochemical reactions with certain neurohormonal peptides and basic peptide sequences. J Histochem Cytochem 34:1469–1476
Sternberger LA (1979) The unlabelled antibody enzyme peroxidase anti-peroxidase (PAP) method. In: Sternberger LA (ed) Immunocytochemistry. John Wiley, New York, pp 104–169
Van Noorden S (1986) Tissue preparation and immunostaining techniques for light microscopy. In: Polak JM, Van Noorden S (eds) Immunocytochemistry. Wright, Bristol, pp 26–53
Varndell IM, Tapia FJ, Probert L, Buchan AMJ, Gu J, De Mey J, Bloom SR, Polak JM (1982) Immunogold staining procedure for the localisation of regulatory peptides. Peptides 3:259–272
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rindi, G., Bishop, A.E., Murphy, D. et al. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice. Vichows Archiv A Pathol Anat 412, 255–266 (1988). https://doi.org/10.1007/BF00737150
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00737150